Indaptus Therapeutics, Inc. Accumulated Other Comprehensive Income
Indaptus Therapeutics, Inc. (INDP) had Accumulated Other Comprehensive Income of $134.16 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2024-03-13
- 2023-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $134.16K.
- 2023-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $177.46K.
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $96.43K.
- 2022-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $15.13K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2023-06-30 | $134.16K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $177.46K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $96.43K 10-K · filed 2024-03-13 |
| 2022-09-30 | $15.13K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$26.94K 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$9.22K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |